Abstract

Introduction: Postoperative atrial fibrillation (POAF) is the most common arrhythmia post coronary artery bypass grafting (CABG). It is associated with an increased morbidity and mortality. Published studies have yielded conflicting results considering the association of preoperative pharmacotherapy with POAF. We assessed the relationship of preoperative medication with POAF in patients undergoing isolated CABG. Methods: We retrospectively studied 226 consecutive patients without history of prior AF, undergoing CABG from September to December 2014. All patients underwent continuous telemetry for ≥5 postoperative days, and POAF was documented using 12-channel electrocardiography. We used univariate and multivariable Logistic regression analyses (adjusted for demographics, cardiovascular risk factors, and the CABG procedure type) to analyse the relationship of preoperative pharmacotherapy with the occurrence of POAF. Results: Of 226 patients (mean age: 63.9±7.9years, female n=54, 23.9%), 53 (23.5%) experienced ≥1 POAF episode until discharge. They were older (65.8±7.3 vs. 63.4±8.0; p=0.049) and less often were taking statins preoperatively compared to non-POAF patients (n=39, 73.6% vs. n=137, 87.2%; p=0.030). There were no significant differences between the groups considering concomitant preoperative comorbidities (e.g., arterial hypertension, diabetes mellitus, chronic obstructive pulmonary disease, etc.), smoking or preoperative medication including amiodarone, beta-blockers, digoxin, diuretics, spironolactone, angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and Ca-antagonists. In a multivariable analysis, preoperative statin use was associated with a 60% risk reduction in POAF incidence (Odds Ratio 0.41; 95% CI 0.19-0.87; p=0.020). Conclusion: We found that preoperative use of statins may reduce the incidence of POAF in patients undergoing isolated CABG.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.